表紙
市場調查報告書

吸入抗菌藥市場 - 規模、佔有率、展望、機會分析 (2020-2027年):各產品類型、用途、流通管道、地區

Inhaled Antibiotics Market, by Product Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948418
出版日期 內容資訊 英文 167 Pages
商品交期: 2-3個工作天內
價格
吸入抗菌藥市場 - 規模、佔有率、展望、機會分析 (2020-2027年):各產品類型、用途、流通管道、地區 Inhaled Antibiotics Market, by Product Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月08日內容資訊: 英文 167 Pages
簡介

帶動吸入抗菌藥市場成長的主要原因中,包含慢性呼吸疾病發生率的上升,迅速的技術進步,及新產品開發的研究開發活動增加。還有,全球市場活動的主要企業,為了擴大產品系列,強化研究開發活動,著重夥伴關係和合作等無機性成長策略的採用。標的型藥物輸送的吸入抗菌藥應用的增加,預計促進在預測期間內的市場成長。

本報告提供全球吸入抗菌藥市場相關調查,市場概要,影響市場的因素分析,各市場區隔、各地區的市場分析,並提供主要企業簡介等資訊。

第1章 調查目的、前提條件

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細 : 各產品類型
    • 市場明細 :各應用領域
    • 市場明細 :各流通管道
    • 市場明細 :各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的發展
  • 法規方案
  • 合併和收購方案
  • PEST分析

第4章 全球吸入抗菌藥市場:冠狀病毒(Covid-19)大流行的影響

  • 影響調查
  • COVID-19前的市場方案
  • COVID-19後的市場方案
  • 為抵抗COVID-19的政府措施

第5章 全球吸入抗菌藥市場:各產品類型

  • 簡介
  • 氣霧劑
  • 乾燥粉末製劑
  • 噴霧

第6章 全球吸入抗菌藥市場:各用途

  • 簡介
  • 肺炎
  • 氣喘
  • 支氣管炎
  • 其他

第7章 全球吸入抗菌藥市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 全球吸入抗菌藥市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Gilead Sciences
    • Aradigm
    • Lupin Ltd.
    • Polyphor
    • Insmed Incorporated
    • Pharmaero
    • Savara Pharmaceuticals
    • Joincare Pharmaceutical Group
    • Pharmaxis Ltd
  • 分析師的見解

第10章 Section

目錄

Title:
Inhaled Antibiotics Market, by Product Type (Aerosol, Dry Powder Formulation, and Spray), by Application (Pneumonia, Asthma, Bronchitis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Inhaled antibiotics are used to treat chronic airway infection. The earliest experience with inhaled antibiotics involved aerosolizing antibiotics designed for parenteral administration. These formulations caused significant bronchial irritation due to added preservatives and non-physiologic chemical composition. A major therapeutic advance took place when tobramycin designed for inhalation was approved by the U.S. Food and Drug Administration (FDA) for use in patients with cystic fibrosis (CF) with chronic Pseudomonas Aeruginosa infection. Increasing application of inhaled antibiotic in targeted drug delivery is expected to drive the market growth over the forecast period.

Market Dynamics

The major factors driving growth of the inhaled antibiotics market include rising incidence of chronic respiratory disorders, rapid technological advancements, and increasing research and development activities for the development of novel products. Moreover, major players operating in the global market are focusing on adoption of inorganic growth strategies such as partnership and collaboration, in order to expand its product portfolio and strengthen their research and development activities. For instance, in October 2019, Alaxia, a French biotech company, partnered with the European consortium iABC, to accelerate the development of ALX-009, an investigational inhaled antibiotic for multi-drug resistant lung infections in people with cystic fibrosis. Under the partnership, Alaxia will provide support for setting up clinical trials and recruiting patients, and will gain access to expertise on antimicrobial agents from iABC members.

Key features of the study:

  • This report provides in-depth analysis of the global inhaled antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global inhaled antibiotics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Gilead Sciences, Aradigm, Lupin Ltd., Polyphor, Insmed Incorporated, Pharmaero, Savara Pharmaceuticals, Joincare Pharmaceutical Group, and Pharmaxis Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global inhaled antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled antibiotics market

Detailed Segmentation:

  • Global Inhaled Antibiotics Market, By Product Type:
    • Aerosol
    • Dry Powder Formulation
    • Spray
  • Global Inhaled Antibiotics Market, By Application:
    • Pneumonia
    • Asthma
    • Bronchitis
    • Others
  • Global Inhaled Antibiotics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Inhaled Antibiotics Market, By Region:
    • North America
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Aerosol
      • Dry Powder Formulation
      • Spray
      • By Application:
      • Pneumonia
      • Asthma
      • Bronchitis
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Gilead Sciences *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Aradigm
    • Lupin Ltd.
    • Polyphor
    • Insmed Incorporated
    • Pharmaero
    • Savara Pharmaceuticals
    • Joincare Pharmaceutical Group
    • Pharmaxis Ltd

"*" marked represents similar segmentation in other categories in the respective section..

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Merger and Acquisition Scenario
  • PEST Analysis

4. Global Inhaled Antibiotics Market - Impact of Coronavirus (Covid-19) Pandemic

  • Impact assessment
  • Pre COVID-19 Market Scenario
  • Post COVID-19 Market Scenario
  • Government measures to combat COVID-19

5. Global Inhaled Antibiotics Market, By Product Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Aerosol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Dry Powder Formulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Inhaled Antibiotics Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pneumonia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Asthma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Bronchitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Inhaled Antibiotics Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Inhaled Antibiotics Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Gilead Sciences *
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aradigm
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lupin Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Polyphor
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Insmed Incorporated
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pharmaero
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Savara Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Joincare Pharmaceutical Group
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pharmaxis Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact